Calumet cut to Sell at UBS on regulatory uncertainty, likely negative revisions

Feb. 04, 2025 3:27 PM ETCalumet, Inc. (CLMT) StockBy: Carl Surran, SA News Editor3 Comments
Group of rows of green stacked biofuel drums in storage warehouse

scanrail/iStock via Getty Images

Calumet Specialty Products (NASDAQ:CLMT) -5.8% in Tuesday's trading as UBS downgrades shares to Sell from Neutral with a $15 price target, slashed from $20.50, citing uncertainty over the Department of Energy's loan, after the Loan Programs Office said the first tranche of the $782M under the

Recommended For You

About CLMT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CLMT--
Calumet, Inc.